[1]
A. Kumer, U. Chakma, and M. M. Matin, “Bilastine Based Drugs as SARS-CoV-2 Protease Inhibitors: Molecular Docking, Dynamics, and ADMET Related Studies”, Orbital: Electron. J. Chem., vol. 14, no. 1, pp. 15-23, Apr. 2022.